IRIS
NAPOLITANO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.959
AS - Asia 6.506
EU - Europa 4.956
SA - Sud America 922
AF - Africa 201
Continente sconosciuto - Info sul continente non disponibili 182
OC - Oceania 14
Totale 21.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.779
CN - Cina 3.285
SG - Singapore 1.389
IE - Irlanda 1.114
HK - Hong Kong 715
BR - Brasile 674
UA - Ucraina 669
IT - Italia 556
DE - Germania 530
RU - Federazione Russa 508
VN - Vietnam 479
FI - Finlandia 386
FR - Francia 380
SE - Svezia 352
GB - Regno Unito 251
IN - India 128
AR - Argentina 86
CA - Canada 83
ZA - Sudafrica 78
BD - Bangladesh 76
JP - Giappone 72
IQ - Iraq 53
MX - Messico 50
PK - Pakistan 46
ID - Indonesia 37
EC - Ecuador 36
NL - Olanda 36
CO - Colombia 33
VE - Venezuela 32
AT - Austria 29
ES - Italia 27
JO - Giordania 23
PH - Filippine 23
UZ - Uzbekistan 23
PL - Polonia 22
MA - Marocco 21
MU - Mauritius 21
BE - Belgio 19
TR - Turchia 19
PY - Paraguay 16
JM - Giamaica 15
MY - Malesia 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
CL - Cile 14
KZ - Kazakistan 14
KE - Kenya 13
PE - Perù 13
TN - Tunisia 13
EG - Egitto 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
PT - Portogallo 9
BO - Bolivia 8
DZ - Algeria 8
NP - Nepal 8
UY - Uruguay 8
AL - Albania 7
IR - Iran 7
LT - Lituania 7
ET - Etiopia 6
GT - Guatemala 6
IL - Israele 6
KW - Kuwait 6
NI - Nicaragua 6
SN - Senegal 6
AU - Australia 5
EU - Europa 5
GE - Georgia 5
GR - Grecia 5
KR - Corea 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
BB - Barbados 3
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
ML - Mali 3
PA - Panama 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CG - Congo 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
Totale 21.521
Salva come PNG Salva come JPEG
Città #
Dublin 1.113
Chandler 1.040
San Jose 951
Jacksonville 857
Ashburn 759
Nanjing 718
Hong Kong 702
Singapore 660
Dallas 576
Beijing 477
Boardman 402
Council Bluffs 331
Nanchang 301
Princeton 259
Lauterbourg 233
Lawrence 233
Wilmington 222
Hebei 219
Changsha 192
Shenyang 188
Los Angeles 187
Ho Chi Minh City 173
Jiaxing 152
Medford 148
New York 132
Helsinki 124
Tianjin 122
Hanoi 119
Milan 116
Shanghai 116
Moscow 104
Buffalo 93
Hangzhou 88
Woodbridge 82
Redondo Beach 80
Santa Clara 77
San Genesio Ed Uniti 69
Ann Arbor 63
Tokyo 62
São Paulo 60
Johannesburg 57
Norwalk 47
Falls Church 46
Falkenstein 44
Verona 42
Seattle 41
Brooklyn 40
Chicago 40
Munich 40
Orem 40
The Dalles 39
Houston 35
San Francisco 34
Nuremberg 33
Columbus 29
Pavia 29
Des Moines 27
Chennai 26
Frankfurt am Main 26
Da Nang 25
Montreal 25
Atlanta 24
Guangzhou 24
Toronto 24
Zhengzhou 23
Kunming 22
Amman 21
Tashkent 21
Rome 20
Fairfield 19
Warsaw 19
Washington 19
London 18
Mexico City 18
Rio de Janeiro 18
Stockholm 18
Baghdad 17
Brussels 17
Jinan 17
Phoenix 17
Thái Nguyên 17
Denver 16
Dhaka 16
Haiphong 16
Lahore 16
Amsterdam 15
Boston 15
Curitiba 15
Guayaquil 15
Naples 15
Palermo 15
Brasília 14
Mumbai 13
Ningbo 12
Buenos Aires 11
Caracas 11
Dearborn 11
Nairobi 11
Pittsburgh 11
Tappahannock 11
Totale 14.017
Salva come PNG Salva come JPEG
Nome #
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 193
Tachicardia Ventricolare Polimorfa Catecolaminergica 174
A method of gene transfer for the treatment of recessive CPVT 172
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 168
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 162
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 149
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 148
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 146
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 145
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 140
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 137
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 136
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 133
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 132
Gene-specific therapy for inherited arrhythmogenic diseases 132
Assessment of a personalized and distributed patient guidance system 132
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 132
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 131
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 131
Computer simulation of wild-type and mutant human cardiac Na+ current 129
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 128
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 127
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 126
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 125
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 124
Risk stratification in the Long-QT Syndrome 121
A Recessive Variant of the Romano-Ward Long QT Syndrome 120
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 120
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 120
Clinical timelines development from textual medical reports in Italian 120
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 119
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 118
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 118
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 117
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 116
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 114
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 113
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 113
Information extraction from Italian medical reports: An ontology-driven approach 113
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 112
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 112
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 111
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 111
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 110
Cardiac Sodium Channel Diseases 108
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 108
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 107
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 107
R Engine Cell: integrating R into the i2b2 software infrastructure. 107
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 107
Supporting shared decision making within the MobiGuide project. 107
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. 106
Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact 106
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 106
A molecular basis for the therapy of the long QT syndrome 106
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 105
Genetic of Long QT, Brugada and Other Channelopathies 105
Evaluation of BLS-D training in lay people. 104
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 103
The role of nurses in e-health: The MobiGuide project experience 103
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 101
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 101
Genetics of ion-channel disorders 100
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 99
Inherited arrhythmia: present and future perspectives for genetic therapy 99
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling 99
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 99
Supervised methods to extract clinical events from cardiology reports in Italian 99
The long QT syndrome 98
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 98
Cardiac ryanodine receptor calcium release deficiency syndrome 98
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 97
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 97
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 97
Flecainide test in Brugada Syndrome: a reproducible but risky tool 97
Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients 96
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 96
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 95
Information Extraction from Italian medical reports: first steps towards clinical timelines development 95
In the RyR2R4496C Mouse Model of CPVT, {beta}-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca Waves. 94
L-TYPE CALCIUM CHANNEL DISEASE 94
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 94
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 94
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 93
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 93
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 93
Clinical and research data integration: the i2b2-FSM experience 93
Brugada syndrome 93
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 92
Timothy Syndrome 92
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 92
Gender Differences in Patients with Brugada Syndrome and Arrhythmic Events: Data from a Survey on Arrhythmic Events in 678 Patients. 92
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 91
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 91
Long QT Syndrome 90
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation 90
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 90
Genetics of Arrhythmogenic Disorders 89
Catecholaminergic Polymorphic Ventricular Tachycardia 89
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 89
Totale 11.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022993 0 0 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/20253.129 58 271 68 88 78 155 191 286 717 128 288 801
2025/20267.008 525 486 919 669 783 301 1.369 268 547 655 283 203
2026/2027812 194 544 74 0 0 0 0 0 0 0 0 0
Totale 21.740